The Quantellect read.As of Nov 19, 2026, 5 active firms cover Addus HomeCare Corporation: 3 rate it Buy or better, 1 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets span $96.00 to $142.00, a moderate spread. The average target of $126.40 sits 5% above the current $120.81. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 3 over recent months. On the fundamentals, the Street sees revenue growth near 7% this year and 5% next, consensus EPS building from about $1.70 next quarter toward $7.60 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Neutral
Strong Buy00%
Buy360%
Neutral120%
Sell120%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$126.40
+4.6% upside
Average target across 5 active firms as of Nov 19, 2026 vs $120.81 current
Highest Target$142.00
Average Target$126.40
Lowest Target$96.00
Detailed analyst forecasts for ADUS
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 3 of 5 active firms rate ADUS a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ADUS EPS & revenue forecast
EPS · NEXT QUARTER
$1.70
Range $1.63 – $1.76 · 6 analysts · +5% YoY
Next period, 6 analysts expect Addus HomeCare Corporation to earn $1.70 a share (range $1.63 – $1.76), versus $1.62 a year earlier. Full-year consensus is $7.08, growing to $7.60 the year after.
REVENUE · NEXT QUARTER
$384.1M
Range $378.9M – $393.1M · 6 analysts · +7% YoY
Revenue is expected to reach $384.1M (range $378.9M – $393.1M), +7.0% year-over-year. Full-year consensus is $1.5B, rising to $1.6B next year.
Top analysts covering Addus HomeCare Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ADUS.
#1
Tao Qiu
Macquarie · Rank #126
Buy
$133.00+10.1% to target
Overall win rate
45%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #150
Buy
$134.00+10.9% to target
Overall win rate
44%
+ Follow
#3
Brian Tanquilut
Jefferies · Rank #280
Buy
$160.00+32.4% to target
Overall win rate
46%
+ Follow
#4
AR
A.J. Rice
UBS · Rank #365
Buy
$145.00+20.0% to target
Overall win rate
35%
+ Follow
#5
Andrew Mok
Barclays · Rank #385
Sell
$96.00-20.5% to target
Overall win rate
39%
+ Follow
ADUS stock forecast FAQ
What is ADUS's average 12-month price target?+
The 5 active firms with a live target average $126.40 for Addus HomeCare Corporation over the next 12 months, ranging from a $142.00 high to a $96.00 low, as of Nov 19, 2026.
Is ADUS stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 5 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 1 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ADUS?+
The Street-high target is $142.00 (Citizens), and the Street-low is $96.00 (Barclays). The average of all 5 active-firm targets is $126.40.
How many active Wall Street firms cover ADUS?+
5 active firms have a recognized rating on Addus HomeCare Corporation as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ADUS?+
Among analysts who currently cover ADUS, Tao Qiu of Macquarie has the strongest overall Quantellect track record (Rank #126). Their current call is Buy with a $133.00 target.
What is Addus HomeCare Corporation's projected EPS for next quarter?+
The consensus estimate is $1.70 per share (range $1.63 – $1.76) across 6 analysts. Full-year EPS is projected at $7.08, rising to $7.60 the following year.
How much revenue is Addus HomeCare Corporation expected to report next quarter?+
Consensus revenue is $384.1M (range $378.9M – $393.1M). Full-year revenue is projected at $1.5B, growing to $1.6B next year.
Have analysts been upgrading or downgrading ADUS lately?+
As of Nov 19, 2026, 3 of 5 active firms rate ADUS a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ADUS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.